DJ Protagonist Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings
(END) Dow Jones Newswires
March 11, 2021 06:42 ET (11:42 GMT)
DJ Protagonist Therapeutics Price Target Raised to $36.00/Share From $33.00 by HC Wainwright & Co.
Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings
(END) Dow Jones Newswires
March 11, 2021 06:42 ET (11:42 GMT)